BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 33574795)

  • 1. Genetic and Epigenetic Causes of Pituitary Adenomas.
    Chang M; Yang C; Bao X; Wang R
    Front Endocrinol (Lausanne); 2020; 11():596554. PubMed ID: 33574795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas.
    Vasilev V; Daly AF; Zacharieva S; Beckers A
    Horm Metab Res; 2020 Aug; 52(8):553-561. PubMed ID: 32299111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Genetic Causes of Pituitary Adenomas.
    Caimari F; Korbonits M
    Clin Cancer Res; 2016 Oct; 22(20):5030-5042. PubMed ID: 27742789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for genetic causes of growth hormone hypersecretion.
    Rostomyan L; Beckers A
    Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Genetics of Pituitary Adenomas.
    Tatsi C; Stratakis CA
    J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31877737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UPDATE ON THE CLINICOPATHOLOGY OF PITUITARY ADENOMAS.
    Lim CT; Korbonits M
    Endocr Pract; 2018 May; 24(5):473-488. PubMed ID: 29498920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on familial pituitary tumors: from multiple endocrine neoplasia type 1 to familial isolated pituitary adenoma.
    Daly AF; Tichomirowa MA; Beckers A
    Horm Res; 2009 Jan; 71 Suppl 1():105-11. PubMed ID: 19153518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of pituitary adenomas.
    Vandeva S; Jaffrain-Rea ML; Daly AF; Tichomirowa M; Zacharieva S; Beckers A
    Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):461-76. PubMed ID: 20833337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.
    Pepe S; Korbonits M; Iacovazzo D
    J Endocrinol; 2019 Feb; 240(2):R21-R45. PubMed ID: 30530903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
    Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on the treatment of pituitary adenomas: familial and genetic considerations.
    Daly AF; Beckers A
    Acta Clin Belg; 2008; 63(6):418-24. PubMed ID: 19170361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
    Beckers A; Daly AF
    Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
    Raitila A; Georgitsi M; Karhu A; Tuppurainen K; Mäkinen MJ; Birkenkamp-Demtröder K; Salmenkivi K; Orntoft TF; Arola J; Launonen V; Vahteristo P; Aaltonen LA
    Endocr Relat Cancer; 2007 Sep; 14(3):901-6. PubMed ID: 17914118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial pituitary adenomas.
    Vandeva S; Vasilev V; Vroonen L; Naves L; Jaffrain-Rea ML; Daly AF; Zacharieva S; Beckers A
    Ann Endocrinol (Paris); 2010 Dec; 71(6):479-85. PubMed ID: 20961530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into pituitary tumorigenesis: from Sanger sequencing to next-generation sequencing and beyond.
    Shen AJJ; King J; Scott H; Colman P; Yates CJ
    Expert Rev Endocrinol Metab; 2019 Nov; 14(6):399-418. PubMed ID: 31793361
    [No Abstract]   [Full Text] [Related]  

  • 17. Sporadic pituitary adenomas: the role of germline mutations and recommendations for genetic screening.
    Iacovazzo D; Hernández-Ramírez LC; Korbonits M
    Expert Rev Endocrinol Metab; 2017 Mar; 12(2):143-153. PubMed ID: 30063429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic and germline mutations in the pathogenesis of pituitary adenomas.
    Vandeva S; Daly AF; Petrossians P; Zacharieva S; Beckers A
    Eur J Endocrinol; 2019 Dec; 181(6):R235-R254. PubMed ID: 31658440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial pituitary tumors.
    Alband N; Korbonits M
    Handb Clin Neurol; 2014; 124():339-60. PubMed ID: 25248598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes.
    Salomon MP; Wang X; Marzese DM; Hsu SC; Nelson N; Zhang X; Matsuba C; Takasumi Y; Ballesteros-Merino C; Fox BA; Barkhoudarian G; Kelly DF; Hoon DSB
    Clin Cancer Res; 2018 Sep; 24(17):4126-4136. PubMed ID: 30084836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.